Malara parasites showing artemisinin resistance previously seen in South-East Asia have recently emerged in areas of Rwanda in Sub-Saharan Africa. If the mutation causing resistance becomes prevalent across the continent it could have major public health impacts.
Staying in a hotel or private accommodation has been associated with carrying ESBL-producing bacteria in travelers to low- and middle-income countries, according to research presented at ECCMID.
The US FDA has granted priority review for Sanofi Pasteur’s dengue vaccine, Dengvaxia®, despite its controversial past.
Globally, shigella is reported to be the third largest cause of diarrheal mortality in the under-fives. We take a look at some of the vaccines that have made it to clinical development and some of the challenges still facing this diarrheal disease.
Blood samples from US athletes and staff who travelled to Rio de Janeiro, Brazil, for the 2016 Summer Games were not infected with Zika virus but tested positive for other viral infections, including West Nile Virus, dengue and chikungunya.
Missed out on attending the British Society for Parasitology’s Autumn Symposium? Read our report of the event here, including talks from Roy Anderson and David Molyneux.
To mark World Rabies Day take a look at our infographic highlighting the current rabies burden and summarizing the strategy aiming to ensure there are zero cases of dog-mediated rabies by 2030.
As of September 14th, fourteen confirmed cases of chikungunya have been reported in Italy, specifically in Rome and the coastal area of the Lazio Region.
With decreasing global boundaries and subsequently increasing travel, we’ve taken a look at five of the most common infectious diseases posing a risk to travelers in our latest infographic.
Is a Zika vaccine imminent? Editor, Martha Powell, provides an overview of the current Zika vaccine candidates in human clinical trials and how these vaccines are being assessed.
